# A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL

> **NCT06779435** · — · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 400 (estimated)

## Conditions studied

- DLBCL

## Interventions

- **DRUG:** Low intensity treatment options
- **DRUG:** Conventional immunochemotherapy regimen

## Key facts

- **NCT ID:** NCT06779435
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06779435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06779435, "A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06779435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*